Jelinek Richard M

SEC source: 0001628908-26-000049 · wk-form4_1780950302.xml · nonDerivative · entry 1

Jelinek Richard M · CIK 0001707429 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,533

F1 · security: Represents restricted stock units granted to Mr. Jelinek pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

F2 · shares: Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date.

SEC source: 0001628908-25-000090 · wk-form4_1749467680.xml · nonDerivative · entry 1

Jelinek Richard M · CIK 0001707429 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,437

F1 · security: Represents restricted stock units granted to Mr. Jelinek pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

F2 · shares: Securities vest on the earlier of June 5, 2026, and the date of the Company's 2026 annual meeting, subject to the reporting person's continued service on the vesting date.

SEC source: 0001628908-25-000048 · wk-form4_1741608974.xml · nonDerivative · entry 2

Jelinek Richard M · CIK 0001707429 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By the Richard M Jelinek GST

Disclosed balance after: 15,000

SEC source: 0001628908-25-000048 · wk-form4_1741608974.xml · nonDerivative · entry 1

Jelinek Richard M · CIK 0001707429 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By the Richard M Jelinek Revocable Trust

Disclosed balance after: 15,000

SEC source: 0001628908-24-000070 · wk-form4_1718062338.xml · nonDerivative · entry 1

Jelinek Richard M · CIK 0001707429 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,458

F1 · security: Represents restricted stock units granted to Mr. Jelinek pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

F2 · shares: Securities vest on the earlier of June 6, 2025, and the date of the Company's 2025 annual meeting, subject to the reporting person's continued service on the vesting date.

SEC source: 0001628908-23-000096 · wf-form4_168662060611901.xml · nonDerivative · entry 1

Jelinek Richard M · CIK 0001707429 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,749

F1 · security: Represents restricted stock units granted to Mr. Jelinek pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

F2 · shares: Securities vest on the earlier of June 8, 2024 and the date of the Company's 2024 annual meeting, subject to the reporting person's continued service on the vesting date.

SEC source: 0000950142-21-004191 · es210211419_4-jelinek.xml · derivative · entry 2

Jelinek Richard M · CIK 0001707429 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · Not disclosed shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: As described in the registration statement on Form S-4 (File No. 333-259639) of Altimar Acquisition Corp. II (the "Issuer"), the shares of Class B ordinary shares of the Issuer (the "Class B Ordinary Shares") held by the reporting person will automatically convert into shares of Class C common stock of Fathom Digital Manufacturing Corporation, a Delaware corporation ("Fathom") in connection with the Business Combination, after which such shares will then automatically convert into Class A common stock of Fathom (the "Class A Common Stock"), after which 7,500 shares of Class A Common Stock will be forfeited by the reporting person, in each case, on a one-for-one basis.

F2 · derivative.exercise_price: On December 23, 2021, the Issuer consummated its initial business combination with Fathom Holdco, LLC, with Fathom as the surviving entity (the "Business Combination"). In connection with the Business Combination, each Class B Ordinary Share of the Issuer ultimately converted to one share of Class A Common Stock of Fathom.

F2 · kind: On December 23, 2021, the Issuer consummated its initial business combination with Fathom Holdco, LLC, with Fathom as the surviving entity (the "Business Combination"). In connection with the Business Combination, each Class B Ordinary Share of the Issuer ultimately converted to one share of Class A Common Stock of Fathom.

F1 · price: As described in the registration statement on Form S-4 (File No. 333-259639) of Altimar Acquisition Corp. II (the "Issuer"), the shares of Class B ordinary shares of the Issuer (the "Class B Ordinary Shares") held by the reporting person will automatically convert into shares of Class C common stock of Fathom Digital Manufacturing Corporation, a Delaware corporation ("Fathom") in connection with the Business Combination, after which such shares will then automatically convert into Class A common stock of Fathom (the "Class A Common Stock"), after which 7,500 shares of Class A Common Stock will be forfeited by the reporting person, in each case, on a one-for-one basis.

F2 · price: On December 23, 2021, the Issuer consummated its initial business combination with Fathom Holdco, LLC, with Fathom as the surviving entity (the "Business Combination"). In connection with the Business Combination, each Class B Ordinary Share of the Issuer ultimately converted to one share of Class A Common Stock of Fathom.

F1 · derivative.exercise_date: As described in the registration statement on Form S-4 (File No. 333-259639) of Altimar Acquisition Corp. II (the "Issuer"), the shares of Class B ordinary shares of the Issuer (the "Class B Ordinary Shares") held by the reporting person will automatically convert into shares of Class C common stock of Fathom Digital Manufacturing Corporation, a Delaware corporation ("Fathom") in connection with the Business Combination, after which such shares will then automatically convert into Class A common stock of Fathom (the "Class A Common Stock"), after which 7,500 shares of Class A Common Stock will be forfeited by the reporting person, in each case, on a one-for-one basis.

F1 · derivative.expiration_date: As described in the registration statement on Form S-4 (File No. 333-259639) of Altimar Acquisition Corp. II (the "Issuer"), the shares of Class B ordinary shares of the Issuer (the "Class B Ordinary Shares") held by the reporting person will automatically convert into shares of Class C common stock of Fathom Digital Manufacturing Corporation, a Delaware corporation ("Fathom") in connection with the Business Combination, after which such shares will then automatically convert into Class A common stock of Fathom (the "Class A Common Stock"), after which 7,500 shares of Class A Common Stock will be forfeited by the reporting person, in each case, on a one-for-one basis.

F1 · derivative.underlying_shares: As described in the registration statement on Form S-4 (File No. 333-259639) of Altimar Acquisition Corp. II (the "Issuer"), the shares of Class B ordinary shares of the Issuer (the "Class B Ordinary Shares") held by the reporting person will automatically convert into shares of Class C common stock of Fathom Digital Manufacturing Corporation, a Delaware corporation ("Fathom") in connection with the Business Combination, after which such shares will then automatically convert into Class A common stock of Fathom (the "Class A Common Stock"), after which 7,500 shares of Class A Common Stock will be forfeited by the reporting person, in each case, on a one-for-one basis.

F2 · derivative.underlying_shares: On December 23, 2021, the Issuer consummated its initial business combination with Fathom Holdco, LLC, with Fathom as the surviving entity (the "Business Combination"). In connection with the Business Combination, each Class B Ordinary Share of the Issuer ultimately converted to one share of Class A Common Stock of Fathom.

SEC source: 0000950142-21-004191 · es210211419_4-jelinek.xml · nonDerivative · entry 1

Jelinek Richard M · CIK 0001707429 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: On December 23, 2021, the Issuer consummated its initial business combination with Fathom Holdco, LLC, with Fathom as the surviving entity (the "Business Combination"). In connection with the Business Combination, each Class B Ordinary Share of the Issuer ultimately converted to one share of Class A Common Stock of Fathom.

F1 · price: As described in the registration statement on Form S-4 (File No. 333-259639) of Altimar Acquisition Corp. II (the "Issuer"), the shares of Class B ordinary shares of the Issuer (the "Class B Ordinary Shares") held by the reporting person will automatically convert into shares of Class C common stock of Fathom Digital Manufacturing Corporation, a Delaware corporation ("Fathom") in connection with the Business Combination, after which such shares will then automatically convert into Class A common stock of Fathom (the "Class A Common Stock"), after which 7,500 shares of Class A Common Stock will be forfeited by the reporting person, in each case, on a one-for-one basis.

F2 · price: On December 23, 2021, the Issuer consummated its initial business combination with Fathom Holdco, LLC, with Fathom as the surviving entity (the "Business Combination"). In connection with the Business Combination, each Class B Ordinary Share of the Issuer ultimately converted to one share of Class A Common Stock of Fathom.

F1 · balance_after: As described in the registration statement on Form S-4 (File No. 333-259639) of Altimar Acquisition Corp. II (the "Issuer"), the shares of Class B ordinary shares of the Issuer (the "Class B Ordinary Shares") held by the reporting person will automatically convert into shares of Class C common stock of Fathom Digital Manufacturing Corporation, a Delaware corporation ("Fathom") in connection with the Business Combination, after which such shares will then automatically convert into Class A common stock of Fathom (the "Class A Common Stock"), after which 7,500 shares of Class A Common Stock will be forfeited by the reporting person, in each case, on a one-for-one basis.

F2 · balance_after: On December 23, 2021, the Issuer consummated its initial business combination with Fathom Holdco, LLC, with Fathom as the surviving entity (the "Business Combination"). In connection with the Business Combination, each Class B Ordinary Share of the Issuer ultimately converted to one share of Class A Common Stock of Fathom.

SEC source: 0000950142-21-001685 · es210150956_4-jelinek.xml · derivative · entry 2

Jelinek Richard M · CIK 0001707429 · See remarks.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · Not disclosed shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: As described in the registration statement on Form S-4 (File No. 333-251866) of Altimar Acquisition Corporation (the "Issuer") under the heading "Certain Relationships and Related Party Transactions," the shares of Class B ordinary shares of the Issuer (the "Class B Ordinary Shares") will automatically convert into shares of Class F common stock of Blue Owl Capital Inc., a Delaware corporation ("Blue Owl") in connection with the domestication, which shares will then automatically convert into Class A common stock of Blue Owl (the "Class A Common Stock") at the time of the Issuer's initial business combination, in each case, on a one-for-one basis, subject to adjustment for share splits, share capitalizations, reorganizations, recapitalizations and the like, and certain anti-dilution rights.

F2 · derivative.exercise_price: On May 19, 2021, the Issuer consummated its initial business combination with Owl Rock Capital Group and Dyal Capital Partners, a division of Neuberger Berman, to form Blue Owl (the "Business Combination"). In connection with the Business Combination, each Class B Ordinary Share of the Issuer ultimately converted to one share of Class A Common Stock of Blue Owl.

F2 · kind: On May 19, 2021, the Issuer consummated its initial business combination with Owl Rock Capital Group and Dyal Capital Partners, a division of Neuberger Berman, to form Blue Owl (the "Business Combination"). In connection with the Business Combination, each Class B Ordinary Share of the Issuer ultimately converted to one share of Class A Common Stock of Blue Owl.

F1 · price: As described in the registration statement on Form S-4 (File No. 333-251866) of Altimar Acquisition Corporation (the "Issuer") under the heading "Certain Relationships and Related Party Transactions," the shares of Class B ordinary shares of the Issuer (the "Class B Ordinary Shares") will automatically convert into shares of Class F common stock of Blue Owl Capital Inc., a Delaware corporation ("Blue Owl") in connection with the domestication, which shares will then automatically convert into Class A common stock of Blue Owl (the "Class A Common Stock") at the time of the Issuer's initial business combination, in each case, on a one-for-one basis, subject to adjustment for share splits, share capitalizations, reorganizations, recapitalizations and the like, and certain anti-dilution rights.

F2 · price: On May 19, 2021, the Issuer consummated its initial business combination with Owl Rock Capital Group and Dyal Capital Partners, a division of Neuberger Berman, to form Blue Owl (the "Business Combination"). In connection with the Business Combination, each Class B Ordinary Share of the Issuer ultimately converted to one share of Class A Common Stock of Blue Owl.

F1 · derivative.exercise_date: As described in the registration statement on Form S-4 (File No. 333-251866) of Altimar Acquisition Corporation (the "Issuer") under the heading "Certain Relationships and Related Party Transactions," the shares of Class B ordinary shares of the Issuer (the "Class B Ordinary Shares") will automatically convert into shares of Class F common stock of Blue Owl Capital Inc., a Delaware corporation ("Blue Owl") in connection with the domestication, which shares will then automatically convert into Class A common stock of Blue Owl (the "Class A Common Stock") at the time of the Issuer's initial business combination, in each case, on a one-for-one basis, subject to adjustment for share splits, share capitalizations, reorganizations, recapitalizations and the like, and certain anti-dilution rights.

F1 · derivative.expiration_date: As described in the registration statement on Form S-4 (File No. 333-251866) of Altimar Acquisition Corporation (the "Issuer") under the heading "Certain Relationships and Related Party Transactions," the shares of Class B ordinary shares of the Issuer (the "Class B Ordinary Shares") will automatically convert into shares of Class F common stock of Blue Owl Capital Inc., a Delaware corporation ("Blue Owl") in connection with the domestication, which shares will then automatically convert into Class A common stock of Blue Owl (the "Class A Common Stock") at the time of the Issuer's initial business combination, in each case, on a one-for-one basis, subject to adjustment for share splits, share capitalizations, reorganizations, recapitalizations and the like, and certain anti-dilution rights.

F1 · derivative.underlying_shares: As described in the registration statement on Form S-4 (File No. 333-251866) of Altimar Acquisition Corporation (the "Issuer") under the heading "Certain Relationships and Related Party Transactions," the shares of Class B ordinary shares of the Issuer (the "Class B Ordinary Shares") will automatically convert into shares of Class F common stock of Blue Owl Capital Inc., a Delaware corporation ("Blue Owl") in connection with the domestication, which shares will then automatically convert into Class A common stock of Blue Owl (the "Class A Common Stock") at the time of the Issuer's initial business combination, in each case, on a one-for-one basis, subject to adjustment for share splits, share capitalizations, reorganizations, recapitalizations and the like, and certain anti-dilution rights.

F2 · derivative.underlying_shares: On May 19, 2021, the Issuer consummated its initial business combination with Owl Rock Capital Group and Dyal Capital Partners, a division of Neuberger Berman, to form Blue Owl (the "Business Combination"). In connection with the Business Combination, each Class B Ordinary Share of the Issuer ultimately converted to one share of Class A Common Stock of Blue Owl.

SEC source: 0000950142-21-001685 · es210150956_4-jelinek.xml · nonDerivative · entry 1

Jelinek Richard M · CIK 0001707429 · See remarks.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: On May 19, 2021, the Issuer consummated its initial business combination with Owl Rock Capital Group and Dyal Capital Partners, a division of Neuberger Berman, to form Blue Owl (the "Business Combination"). In connection with the Business Combination, each Class B Ordinary Share of the Issuer ultimately converted to one share of Class A Common Stock of Blue Owl.

F1 · price: As described in the registration statement on Form S-4 (File No. 333-251866) of Altimar Acquisition Corporation (the "Issuer") under the heading "Certain Relationships and Related Party Transactions," the shares of Class B ordinary shares of the Issuer (the "Class B Ordinary Shares") will automatically convert into shares of Class F common stock of Blue Owl Capital Inc., a Delaware corporation ("Blue Owl") in connection with the domestication, which shares will then automatically convert into Class A common stock of Blue Owl (the "Class A Common Stock") at the time of the Issuer's initial business combination, in each case, on a one-for-one basis, subject to adjustment for share splits, share capitalizations, reorganizations, recapitalizations and the like, and certain anti-dilution rights.

F2 · price: On May 19, 2021, the Issuer consummated its initial business combination with Owl Rock Capital Group and Dyal Capital Partners, a division of Neuberger Berman, to form Blue Owl (the "Business Combination"). In connection with the Business Combination, each Class B Ordinary Share of the Issuer ultimately converted to one share of Class A Common Stock of Blue Owl.

SEC source: 0001122304-18-000161 · edgar.xml · derivative · entry 7

Jelinek Richard M · CIK 0001707429 · EVP, Enterprise Strategy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,377 shares

Expires not disclosed

F8 · derivative.exercise_price: RSUs granted under the Plan on March 2, 2018. These RSUs were converted to CVS Health RSUs pursuant to the Merger Agreement.

F8 · price: RSUs granted under the Plan on March 2, 2018. These RSUs were converted to CVS Health RSUs pursuant to the Merger Agreement.

F8 · derivative.exercise_date: RSUs granted under the Plan on March 2, 2018. These RSUs were converted to CVS Health RSUs pursuant to the Merger Agreement.

F8 · derivative.expiration_date: RSUs granted under the Plan on March 2, 2018. These RSUs were converted to CVS Health RSUs pursuant to the Merger Agreement.

SEC source: 0001122304-18-000161 · edgar.xml · derivative · entry 6

Jelinek Richard M · CIK 0001707429 · EVP, Enterprise Strategy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,939 shares

Expires not disclosed

F7 · derivative.exercise_price: PSUs earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 17, 2017. These PSUs were converted to time-vesting CVS Health RSUs pursuant to the terms of the Merger Agreement.

F7 · price: PSUs earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 17, 2017. These PSUs were converted to time-vesting CVS Health RSUs pursuant to the terms of the Merger Agreement.

F7 · derivative.exercise_date: PSUs earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 17, 2017. These PSUs were converted to time-vesting CVS Health RSUs pursuant to the terms of the Merger Agreement.

F7 · derivative.expiration_date: PSUs earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 17, 2017. These PSUs were converted to time-vesting CVS Health RSUs pursuant to the terms of the Merger Agreement.

SEC source: 0001122304-18-000161 · edgar.xml · derivative · entry 5

Jelinek Richard M · CIK 0001707429 · EVP, Enterprise Strategy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,200 shares

Expires not disclosed

F6 · derivative.exercise_price: Represents Performance Stock Units ("PSUs") earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 19, 2016. These PSUs were converted to time-vesting CVS Health Restricted Stock Units ("RSUs") pursuant to the terms of the Merger Agreement.

F6 · price: Represents Performance Stock Units ("PSUs") earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 19, 2016. These PSUs were converted to time-vesting CVS Health Restricted Stock Units ("RSUs") pursuant to the terms of the Merger Agreement.

F6 · derivative.exercise_date: Represents Performance Stock Units ("PSUs") earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 19, 2016. These PSUs were converted to time-vesting CVS Health Restricted Stock Units ("RSUs") pursuant to the terms of the Merger Agreement.

F6 · derivative.expiration_date: Represents Performance Stock Units ("PSUs") earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 19, 2016. These PSUs were converted to time-vesting CVS Health Restricted Stock Units ("RSUs") pursuant to the terms of the Merger Agreement.

SEC source: 0001122304-18-000161 · edgar.xml · derivative · entry 4

Jelinek Richard M · CIK 0001707429 · EVP, Enterprise Strategy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 79,938 shares

Expires not disclosed

F5 · price: Represents SARs granted under the Plan on February 17, 2017, of which 33.3% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement.

F5 · derivative.exercise_date: Represents SARs granted under the Plan on February 17, 2017, of which 33.3% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement.

F5 · derivative.expiration_date: Represents SARs granted under the Plan on February 17, 2017, of which 33.3% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement.

SEC source: 0001122304-18-000161 · edgar.xml · derivative · entry 3

Jelinek Richard M · CIK 0001707429 · EVP, Enterprise Strategy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 81,038 shares

Expires not disclosed

F4 · price: Represents SARs granted under the Plan on February 19, 2016, of which 66.7% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement.

F4 · derivative.exercise_date: Represents SARs granted under the Plan on February 19, 2016, of which 66.7% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement.

F4 · derivative.expiration_date: Represents SARs granted under the Plan on February 19, 2016, of which 66.7% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement.

SEC source: 0001122304-18-000161 · edgar.xml · derivative · entry 2

Jelinek Richard M · CIK 0001707429 · EVP, Enterprise Strategy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 16,806 shares

Expires not disclosed

F3 · price: Represents Stock Appreciation Rights ("SARs") granted pursuant to the Aetna Inc. 2010 Stock Incentive Plan (the "Plan") on November 2, 2015. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date, less (c) the exercise price (the "SAR Amount").

F3 · derivative.exercise_date: Represents Stock Appreciation Rights ("SARs") granted pursuant to the Aetna Inc. 2010 Stock Incentive Plan (the "Plan") on November 2, 2015. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date, less (c) the exercise price (the "SAR Amount").

F3 · derivative.expiration_date: Represents Stock Appreciation Rights ("SARs") granted pursuant to the Aetna Inc. 2010 Stock Incentive Plan (the "Plan") on November 2, 2015. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date, less (c) the exercise price (the "SAR Amount").

SEC source: 0001122304-18-000161 · edgar.xml · nonDerivative · entry 1

Jelinek Richard M · CIK 0001707429 · EVP, Enterprise Strategy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · shares: Includes 140 shares acquired under Aetna Inc. Employee Stock Purchase Plan on June 1, 2018.

F2 · price: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock.

SEC source: 0001122304-18-000035 · edgar.xml · derivative · entry 1

Jelinek Richard M · CIK 0001707429 · EVP, Enterprise Strategy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,377

Underlying: Common Stock · 23,377 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a right to receive one share of Aetna Inc. Common Stock net of taxes.

F2 · derivative.exercise_date: RSUs granted under the Plan vest in three annual installments beginning December 2, 2018.

F2 · derivative.expiration_date: RSUs granted under the Plan vest in three annual installments beginning December 2, 2018.

SEC source: 0001122304-17-000145 · edgar.xml · derivative · entry 6

Jelinek Richard M · CIK 0001707429 · EVP, Enterprise Strategy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 26,011 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Each Restricted Stock Unit represents a right to receive one share of Aetna Inc. Common Stock net of taxes.

F8 · derivative.exercise_date: RSUs granted under the Plan.

F8 · derivative.expiration_date: RSUs granted under the Plan.

SEC source: 0001122304-17-000145 · edgar.xml · derivative · entry 5

Jelinek Richard M · CIK 0001707429 · EVP, Enterprise Strategy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,276 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Performance Stock Unit represents a right to receive up to two shares of Aetna Inc. Common Stock net of taxes.

F7 · derivative.exercise_date: PSUs granted under the Plan.

F7 · derivative.expiration_date: PSUs granted under the Plan.

SEC source: 0001122304-17-000145 · edgar.xml · nonDerivative · entry 4

Jelinek Richard M · CIK 0001707429 · EVP, Enterprise Strategy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,087

F6 · shares: Represents tax withholding on vesting of previously reported RSUs.

F9 · balance_after: Includes 168 shares acquired under the Aetna Inc. 2016 Employee Stock Purchase Plan on December 1, 2017

SEC source: 0001122304-17-000145 · edgar.xml · nonDerivative · entry 3

Jelinek Richard M · CIK 0001707429 · EVP, Enterprise Strategy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,501

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · shares: Represents vesting of previously reported Restricted Stock Units (RSUs) granted under the Plan.

F5 · price: Each Restricted Stock Unit represents a right to receive one share of Aetna Inc. Common Stock net of taxes.

SEC source: 0001122304-17-000145 · edgar.xml · nonDerivative · entry 2

Jelinek Richard M · CIK 0001707429 · EVP, Enterprise Strategy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,490

F3 · shares: Represents tax withholding on vesting of previously reported PSUs.

SEC source: 0001122304-17-000145 · edgar.xml · nonDerivative · entry 1

Jelinek Richard M · CIK 0001707429 · EVP, Enterprise Strategy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,900

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents vesting of previously reported Performance Stock Units (PSUs) granted under the 2010 Stock Incentive Plan (the "Plan").

F2 · price: Each Performance Stock Unit represents a right to receive up to two shares of Aetna Inc. Common Stock net of taxes.

SEC source: 0001122304-17-000137 · edgar.xml · derivative · entry 1

Jelinek Richard M · CIK 0001707429 · EVP, Enterprise Strategy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,276

Underlying: Common Stock · 2,276 shares

Expires not disclosed

F1 · derivative.exercise_price: Performance Stock Units ("PSUs") granted under the Aetna Inc. 2010 Stock Incentive Plan. Each PSU represents a right to receive up to two shares of Aetna Inc. Common Stock net taxes, depending on performance against the specified Company performance target.

F2 · derivative.exercise_date: PSUs originally granted on November 2, 2015. Units vest based on both service and attaining the specified Company performance target. On December 19, 2017, the Company's Committee on Compensation and Talent Management determined that the performance target had been met at a specified level for the performance period.

F2 · derivative.expiration_date: PSUs originally granted on November 2, 2015. Units vest based on both service and attaining the specified Company performance target. On December 19, 2017, the Company's Committee on Compensation and Talent Management determined that the performance target had been met at a specified level for the performance period.